The impact of self-quarantining on diabetes self-management and distress during the coronavirus outbreak

The impact of self-quarantining on diabetes self-management and distress during the coronavirus outbreak - COVID-19 glycemic control study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49865

Enrollment

318

Registered

2020-04-29

Start date

2020-05-02

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes diabetes mellitus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Type 1 or type 2 diabetes mellitus - 18 years or older - Ability to perform fingerprick HbA1c self-measurement - Sufficient Dutch language comprehension - Ability to fill out online questionnaire

Exclusion criteria

Exclusion criteria: - Pregnancy - Newly diagnosed malignancy, with the exclusion of non-melanoma skin cancer, in the previous 6 months - Chemotherapy or immunotherapy for malignancy - Admission to hospital or rehabilitation center

Design outcomes

Primary

Measure	Time frame
To determine the effect of a period of nationwide self-quarantine on glycemic control, assessed by HbA1c, in patients with type 1 and type 2 diabetes	—

Secondary

Measure	Time frame
- To determine the effect of a period of nationwide self-quarantine on glucose variability assessed by the standard deviation (SD) of glucose values (glucose variability) in patients with type 1 and type 2 diabetes - To assess the association between (diabetes) distress and glycemic control during a period of nationwide self-quarantine. (Diabetes) distress will be measured by Perceived Stress Scale(PSS) and Problem Areas in Diabetes (PAID). - To assess the association between well-being and glycemic control during a period of nationwide self-quarantine. Well-being will be measured by the WHO-5. - To assess the association between between diabetes self-management and glycemic control during a period of nationwide self-quarantine. Self-management behaviour will be measured by the Summary of Diabetes Self-Care Activities (SDSCA) and Diabetes Self-Management Questionnaire-rev. (DSMQ-R) - To determine differences HbA1c, glucose variability, well-being, distress and self-management between patients with type 1 and type 2 diabetes	—

Measure

Time frame

- To determine the effect of a period of nationwide self-quarantine on glucose variability assessed by the standard deviation (SD) of glucose values (glucose variability) in patients with type 1 and type 2 diabetes - To assess the association between (diabetes) distress and glycemic control during a period of nationwide self-quarantine. (Diabetes) distress will be measured by *Perceived Stress Scale*(PSS) and *Problem Areas in Diabetes* (PAID). - To assess the association between well-being and glycemic control during a period of nationwide self-quarantine. Well-being will be measured by the WHO-5. - To assess the association between between diabetes self-management and glycemic control during a period of nationwide self-quarantine. Self-management behaviour will be measured by the *Summary of Diabetes Self-Care Activities* (SDSCA) and *Diabetes Self-Management Questionnaire-rev.* (DSMQ-R) - To determine differences HbA1c, glucose variability, well-being, distress and self-management between patients with type 1 and type 2 diabetes

—

Countries

Netherlands

Outcome results